Previous Close | 0.0729 |
Open | 0.0725 |
Bid | 0.0750 x 8100 |
Ask | 0.0767 x 15000 |
Day's Range | 0.0713 - 0.0788 |
52 Week Range | 0.0510 - 1.2200 |
Volume | |
Avg. Volume | 37,828,586 |
Market Cap | 17.59M |
Beta (5Y Monthly) | 1.32 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.8700 |
Earnings Date | Apr 01, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Click here to register for April 1 investor webcastCompany plans to file its Earnings Report on April 1, 2024 on Form 10-K for the year ended December 31, 2023 SAN FRANCISCO, CA / ACCESSWIRE / March 27, 2024 /Jaguar Health, Inc. (NASDAQ:JAGX) today ...
Agreement terms to include payment of double-digit royalties to Jaguar on all Crofelemer products sold in the licensed territory SAN FRANCISCO, CA / ACCESSWIRE / March 20, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that it ...
SAN FRANCISCO, CA / ACCESSWIRE / February 23, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today provided an update regarding the status of its listing with The Nasdaq Stock Market LLC ("Nasdaq"). "Jaguar requested a hearing ...